Home » Topics » BioWorld Science

BioWorld Science
RSS

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical describe TLR7 agonists

Aug. 16, 2018

Nuclear receptor ROR-gamma inverse agonists discovered at Genfit

Aug. 16, 2018

Shanghai Longwood Biopharmaceuticals identifies hepatitis B caspid assembly inhibitors

Aug. 16, 2018

Proteasome inhibitors patented by Chengdu Origin Biotechnology

Aug. 16, 2018

Hefei Institutes of Physical Sciences divulges EZH2 inhibitors

Aug. 16, 2018

IND approval received in China for phase Ib/III study of CAN-017 as treatment of ESCC

Aug. 16, 2018

Brain immune cells mediate arthritic joint pain

Aug. 16, 2018

Entasis announces positive topline phase II data for ETX-2514 plus sulbactam in patients with cUTI

Aug. 16, 2018

First patient treated in Escalier Biosciences' phase I/IIa study of ESR-114

Aug. 16, 2018

Preclinical studies identify a potential drug target for the treatment of neuroblastoma

Aug. 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...